6127.HK
6127.HK
CNE100004BP3
JOINN
Loading chart...

Company Profile

Joinn Laboratories(China)Co.,Ltd. provides preclinical and non-clinical services in the United States, the People's Republic of China, and internationally. It operates through three segments: Non-Clinical Studies Services; Clinical Trial and Related Services; and Sales of Research Models. The Non-Clinical Studies Services segment offers drug safety assessment, drug metabolism and pharmacokinetics DMPK studies, and pharmacology and efficacy studies. Its Clinical Trial and Related Services segment provide clinical contract research organization services, co-managed phase I clinical research units, and bioanalytical services. The Sales of Research Models segment engages in the design, production, breeding, and sale of research models, including non-human primates and rodents. The company also offers cell-based assay (CBA) services. In addition, it offers drug quality research and testing services for protein drugs, vaccines, gene and cell therapy products, and provides customized solutions for early-stage drug discovery, screening, and mechanism research. Joinn Laboratories(China)Co.,Ltd. was incorporated in 1995 and is headquartered in Beijing, China.

Related stocks

300676.SZ
300676.SZ • China
BGI GENOMICS
45.47 CNY
2.85B USD 1Y -9.3%
603127.SS
603127.SS • China
JOINN LABORATORIES (CHINA) CO L
52.6 CNY
5.9B USD 1Y +47.6%
300244.SZ
300244.SZ • China
D.A. DIAGNOSTICS
20.4 CNY
1.91B USD 1Y +24.4%
SAILIFE.NS
SAILIFE.NS • India
SAI LIFE SCIENCES LIMITED
1,487.9 INR
3.27B USD 1Y +74.7%
3347.HK
3347.HK • China
TIGERMED
44.56 HKD
4.89B USD 1Y +3.2%
603882.SS
603882.SS • China
GUANGZHOU KINGMED DIAGNOSTICS G
28.82 CNY
2B USD 1Y -3.4%
300347.SZ
300347.SZ • China
TIGERMED
55.18 CNY
7.11B USD 1Y -3%
603108.SS
603108.SS • China
SHANGHAI RUNDA MEDICAL TECHNOLO
9.97 CNY
901.98M USD 1Y -36.5%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile
5 Metrics

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High
5Y Volatility
70.5% p.a.
Max Drawdown (5Y)
-88.2%
Sharpe Ratio (5Y)
-0.18
Beta Factor
0.87
Size Class
Large Cap
Notes & Warnings
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Exemplary balance sheet strength: Very solid ratio of equity to debt.
🔴 Low analyst coverage – higher uncertainty in growth estimates & projections
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (70.5% p.a.).
Historical Stress Test: Maximum peak-to-trough drawdown of -88.2% in the extended horizon.
ende